SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-006278
Filing Date
2023-08-18
Accepted
2023-08-18 17:00:29
Documents
54
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm   iXBRL 10-Q 440915
2 CERTIFICATION nbio_ex311.htm EX-31.1 10211
3 CERTIFICATION nbio_ex312.htm EX-31.2 9749
4 CERTIFICATION nbio_ex321.htm EX-32.1 3462
5 CERTIFICATION nbio_ex322.htm EX-32.2 3760
  Complete submission text file 0001477932-23-006278.txt   2896723

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20230630.xsd EX-101.SCH 45126
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20230630_lab.xml EX-101.LAB 219997
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20230630_cal.xml EX-101.CAL 32423
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20230630_pre.xml EX-101.PRE 187187
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20230630_def.xml EX-101.DEF 95010
48 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10q_htm.xml XML 311168
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 231186549
SIC: 2834 Pharmaceutical Preparations